| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 28, 2025 | CDNA Caredx, Inc. | Hagstrom William A | Director | Sell | 30,000 | $17.45 | $523,413.00 | -35.7% | |
| May 28, 2025 | MTD Mettler Toledo International Inc/ | Kelly Michael A | Director | Sell | 1,062 | $1,159.93 | $1,231,845.66 | -89.8% | |
| May 28, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew | Executive Chairman | Sell | 20,000 | $157.45 | $3,149,000.00 | -20.0% | |
| May 27, 2025 | FLGT Fulgent Genetics, Inc. | Xie Jian | President And COO | Sell | 1,873 | $20.54 | $38,468.45 | -0.3% | |
| May 27, 2025 | FLGT Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | Sell | 1,039 | $20.54 | $21,339.43 | - | |
| May 27, 2025 | PRPO Precipio, Inc. | Sandberg Richard A | Director | Buy | 101 | $9.80 | $989.80 | +0.3% | |
| May 27, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 1,438 | $156.85 | $225,551.02 | -0.9% | |
| May 27, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 1,649 | $156.85 | $258,646.47 | -1.3% | |
| May 27, 2025 | NEO Neogenomics Inc | Kelly Michael Aaron | Director | Buy | 5,000 | $7.60 | $38,000.00 | New | |
| May 23, 2025 | TWST Twist Bioscience Corp | Werner Robert F. | Chief Accounting Officer | Sell | 839 | $27.73 | $23,263.79 | -1.6% | |
| May 23, 2025 | RDNT Radnet, Inc. | Sorensen Alma Gregory | EVP, Chief Science Officer | Sell | 100,000 | $56.74 | $5,674,100.00 | -4.0% | |
| May 22, 2025 | PRPO Precipio, Inc. | Sandberg Richard A | Director | Buy | 500 | $9.33 | $4,665.00 | +1.3% | |
| May 21, 2025 | TWST Twist Bioscience Corp | Finn Patrick John | President And COO | Sell | 1,877 | $29.75 | $55,835.12 | -0.8% | |
| May 21, 2025 | TWST Twist Bioscience Corp | Leproust Emily M. | Chief Executive Officer | Sell | 2,802 | $29.75 | $83,351.09 | -0.4% | |
| May 21, 2025 | TWST Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Sell | 936 | $29.75 | $27,843.19 | -0.9% | |
| May 21, 2025 | TWST Twist Bioscience Corp | Werner Robert F. | Chief Accounting Officer | Sell | 242 | $29.75 | $7,198.77 | -0.5% | |
| May 21, 2025 | TWST Twist Bioscience Corp | Green Paula | SVP Of Human Resources | Sell | 632 | $29.75 | $18,800.10 | -0.5% | |
| May 21, 2025 | TWST Twist Bioscience Corp | Cho Dennis | See Remarks | Sell | 531 | $29.75 | $15,795.66 | -0.5% | |
| May 21, 2025 | PRPO Precipio, Inc. | Sandberg Richard A | Director | Buy | 8,035 | $9.27 | $74,473.75 | +12.3% | |
| May 20, 2025 | PRPO Precipio, Inc. | Sandberg Richard A | Director | Buy | 4,251 | $8.47 | $36,005.97 | +16.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.